Samuel Bates Martin, SVP AND CFO at Celldex Therapeutics, Inc. (CLDX), sold 38,779 shares at $36.76 ($1.4M) on 2022-08-12, disclosed to the SEC on 2022-08-15.
Open-market sale of $1.4M CLDX by SVP AND CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.04 | 2,453 | $91K | 6.4% |
| 2 | $37.04 | 2,453 | $91K | 6.4% |
| 3 | $34.62 | 1,221 | $42K | 3.0% |
| 4 | $35.38 | 2,065 | $73K | 5.2% |
| 5 | $35.38 | 2,065 | $73K | 5.2% |
| 6 | $36.76 | 14,261 |
| $524K |
| 37.0% |
| 7 | $36.76 | 14,261 | $524K | 37.0% |
| Total | $36.58 avg | 38,779 | $1.4M | 100% |
| Filing → |
| CLDX | SELL | 2021-12-28 | $399K | — | Filing → |
| CLDX | SELL | 2021-11-17 | $828K | — | Filing → |
| CLDX | SELL | 2021-08-12 | $124K | — | Filing → |